We are proud to support the development of promising early career scientists through the Milton Safenowitz Postdoctoral Fellowship. The Safenowitz family established this award in memory of Milton Safenowitz, who died of ALS in 1998. The fellowship encourages junior postdoctoral researchers to enter and, importantly, remain in the ALS field.
Elizabeth Bradley lost her husband Woody to ALS, and has used his passing as inspiration to pursue a Master of Science in Psychology.
To complete her research project, she needs survey responses soon!
ALS Focus recently launched its third survey, gathering data from ALS caregivers to identify the unique needs and challenges of ALS caregiving. Responses to this survey will help translate the caregiver experience into action and influence ALS programs and policy decisions. ALS Focus Director Dr. Sarah Parvanta detailed the questions her team is asking in the current survey during a recent episode of Connecting ALS. A portion of that conversation has been edited and condensed below.
Randy was a man with heart and courage as he confronted his brief eighteenth month journey with ALS. While our family is so proud of how he faced the incomprehensible challenges and losses from ALS we also want others to know and remember the man Randy was before ALS entered the scene, the man ALS was powerless to destroy.
A simple sentence can help change the future of ALS. By making The ALS Association a beneficiary of your estate plan you can help ensure future generations live our shared vision of a world without ALS.
In celebration of mothers everywhere today, we are honored to share the story of celebrity hairdresser and beauty expert, Ken Paves, and his amazing story about life, love and caring for his beautiful mother, Helen, who recently lost her battle with ALS.
More clinical trials and more participants mean more opportunities to find new treatments and a cure for ALS. We are proud to support established and emerging sites like these through our Trial Capacity Awards as they work to improve trial accessibility for people with ALS and the efficiency and pace at which this research is conducted.